ARK Investment Management Big Ideas 2019 CRISPR Gene Editing

ARK Investment Management's 2019 research report exploring CRISPR gene-editing technology as a revolutionary approach to treating genetic diseases including sickle cell anemia, cystic fibrosis, and childhood blindness. The analysis highlights early clinical trials underway in the United States and projects significant market opportunities driven by the technology's ease of use, cost-efficiency, and safety profile.